GenHealth.ai
Use Cases
Products
Company
Research
Get a Demo
See how we Automate Prior Authorization
Use our Population Health Analytics Co-pilot
Search all medical codes
R97.21
Rising PSA following treatment for malignant neoplasm of prostate
ICD10CM code
Medical Policies and Guidelines for Rising PSA following treatment for malignant neoplasm of prostate
Related policies from health plans
ANTHEM-BLUECROSS-CA
Provenge (sipuleucel-T)
ANTHEM-BLUECROSS-CA
Xofigo (Radium Ra 223 Dichloride)
Similar Codes
ICD10CM codes
R97.21
- Rising PSA following treatment for malignant neoplasm of prostate
R97.20
- Elevated prostate specific antigen [PSA]
R97.2
- Elevated prostate specific antigen [PSA]
C61
- Malignant neoplasm of prostate
Z85.46
- Personal history of malignant neoplasm of prostate
Z12.5
- Encounter for screening for malignant neoplasm of prostate
Z80.42
- Family history of malignant neoplasm of prostate
N52.31
- Erectile dysfunction following radical prostatectomy
D29.1
- Benign neoplasm of prostate
N52.37
- Erectile dysfunction following prostate ablative therapy
HCPCS codes
G0103
- Prostate cancer screening; prostate specific antigen test (psa)
G0102
- Prostate cancer screening; digital rectal examination
G9842
- Patient has metastatic disease at diagnosis
G8875
- Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method
G9549
- Documentation of medical reason(s) that follow-up imaging is indicated (e.g., patient has lymphadeno
G9555
- Documentation of medical reason(s) for recommending follow up imaging (e.g., patient has multiple en
G9310
- Unplanned hospital readmission within 30 days of principal procedure
G9754
- A finding of an incidental pulmonary nodule
G9097
- Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as
G9396
- Patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve m
CPT4 codes
84153
- Prostate specific antigen (PSA); total
3273F
- High risk of recurrence, prostate cancer (PRCA)
3272F
- Intermediate risk of recurrence, prostate cancer (PRCA)
81539
- Oncology (high-grade prostate cancer), biochemical assay of four proteins (Total PSA, Free PSA, Inta
0010M
- Oncology (High-Grade Prostate Cancer), biochemical assay of four proteins (Total PSA, Free PSA, Inta
84152
- Prostate specific antigen (PSA); complexed (direct measurement)
84154
- Prostate specific antigen (PSA); free
3271F
- Low risk of recurrence, prostate cancer (PRCA)
81541
- Oncology (prostate), mRNA gene expression profiling by real-time RT-PCR of 46 genes (31 content and
0005U
- Oncology (prostate) gene expression profile by real-time RT-PCR of 3 genes (ERG, PCA3, and SPDEF), u
Choose how you'd like to learn more
Email
Send us a message or questions and we can share more details.
Name
Email
Message
Company Name
Submit
Meet
Setup a calendar meeting with us; find a time now.
DIY Demo
Sign up for a free account to see our product in action.
Demo Gen AI Healthcare Analytics